Related Experiment Video
Updated: Jun 22, 2025
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.6K
Successful laparoscopic retroperitoneal tumor resection using mixed reality and guiding marker techniques
Yoichiro Tohi1, Homare Okazoe1, Katsuya Mitamura2
1Department of Urology, Faculty of Medicine Kagawa University Kita-gun Kagawa Japan.
IJU Case Reports
|July 5, 2024
Summary
Mixed reality (MR) surgery with a guiding marker precisely located and resected small retroperitoneal tumors. This innovative approach enhanced surgical accuracy for difficult-to-identify metastatic uterine cancer.
Area of Science:
- Surgical Oncology
- Medical Technology
- Gastrointestinal Surgery
Background:
- Small tumors, particularly retroperitoneal metastasis, pose challenges for accurate visual identification and preoperative localization.
- Advancements in mixed reality (MR) technology offer potential solutions for enhancing surgical precision across various medical disciplines.
Observation:
- A 67-year-old female patient with uterine cancer presented with a 2 cm retroperitoneal metastasis near the right diaphragm.
- Preoperative surgical planning was conducted using the "Holoeyes" MR software on a HoloLens2 head-mounted display.
Findings:
- The surgical team employed ultrasonography-guided placement of a guiding marker for precise tumor localization.
- Mixed reality-assisted navigation facilitated strategic port-site placement, enabling accurate laparoscopic tumor resection.
- The procedure resulted in minimal blood loss and no intraoperative complications.
Implications:
- Mixed reality-assisted surgery, combined with guiding markers, significantly improves the precision of retroperitoneal tumor resection.
- This technology holds promise for improving outcomes in complex oncologic surgeries involving small or difficult-to-locate tumors.
- The integration of MR in surgical workflows can lead to safer and more effective patient treatments.
